Iohexol: effects on uptake of radioactive iodine in the thyroid and on thyroid function.

RATIONALE AND OBJECTIVES The authors attempted to determine whether the use of nonionic contrast media causes uptake of iodine by the thyroid to be blocked and whether use of these agents could cause iodine-induced hyperthyroidism. MATERIALS AND METHODS Twenty-eight persons, including 22 with thyroid disease, were included in the study. Subjects underwent computed tomography (CT) of the thyroid after injection of 100 mL of iohexol. Thyroid function variables were measured before CT scanning and 1 week and 1 month later. In 16 subjects, uptake of iodine-131 by the thyroid was measured before and 1 week after CT. RESULTS I-131 uptake was reduced to 53.4% at 1 week after the injection of iohexol but became normal within a few weeks (followed up in one patient). An accelerated escape of I-131 from the thyroid was seen during the 1st days after the iohexol administration. Eight of 22 patients with an underlying thyroid disease had a temporary change in thyroid function. In four patients, the serum thyrotropin level was increased 1 week after the iohexol administration. In four other patients, temporary hyperthyroidism developed during the following months. CONCLUSION Iohexol can be used in patients with an underlying thyroid disease, but close monitoring in the following months is necessary.

[1]  E. Lasser,et al.  Contrast material iodides: potential effects on radioactive iodine thyroid uptake. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  R. Utiger,et al.  Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. , 1975, The Journal of clinical endocrinology and metabolism.

[3]  P. Laurberg,et al.  Inhibitory effect of various radiographic contrast agents on secretion of thyroxine by the dog thyroid and on peripheral and thyroidal deiodination of thyroxine to tri-iodothyronine. , 1987, Journal of Endocrinology.

[4]  B. Olsson,et al.  Human pharmacokinetics of iohexol. A new nonionic contrast medium. , 1983, Investigative radiology.

[5]  L. Hegedüs,et al.  131I treatment of nodular non-toxic goitre. , 1996, European journal of endocrinology.

[6]  D. Solomon,et al.  Comparison sodium ipodate (oragrafin) and propylthiouracil in early treatment of hyperthyroidism. , 1982, The Journal of clinical endocrinology and metabolism.

[7]  T. Kozuka,et al.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. , 1990, Radiology.

[8]  J. Franklyn,et al.  Drug-Induced Thyroid Disorders , 1995, Drug safety.

[9]  L. Braverman,et al.  COMPARATIVE EFFECTS OF SODIUM IPODATE AND IODIDE ON SERUM THYROID HORMONE CONCENTRATIONS IN PATIENTS WITH GRAVES' DISEASE , 1985, Clinical endocrinology.

[10]  P. Colman,et al.  Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. , 1993, The American journal of medicine.

[11]  L. Lipworth,et al.  Suppression of thyroid radioiodine uptake by various doses of stable iodide. , 1980, The New England journal of medicine.

[12]  M. Westhoff-Bleck,et al.  The Adverse Effects of Angiographic Radiocontrast Media , 1991, Drug safety.

[13]  M. Wellby,et al.  The effects of iopodate on the serum iodothyronine pattern in normal subjects. , 1980, Acta endocrinologica.

[14]  L. Sobrinho,et al.  Thyroxine toxicosis in patients with iodine induced thyrotoxicosis. , 1977, The Journal of clinical endocrinology and metabolism.

[15]  J. Hershman,et al.  Treatment of hyperthyroidism with sodium ipodate (oragrafin) in addition to propylthiouracil and propranolol. , 1981, The Journal of clinical endocrinology and metabolism.